LP
BNGO icon

LMR Partners’s Bionano Genomics BNGO Stock Holding History

LMR Partners’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-95
Closed -$34.6K – 947
2023
Q2 		$34.6K Buy
+95
New +$42.9K ﹤0.01% 693
2021
Q1 		– Sell
-23
Closed -$42K – 963
2020
Q4 		$42K Buy
+23
New +$8.59K ﹤0.01% 467

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LMR Partners's BNGO Position: Q3 2023 in Review

LMR Partners sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 95 shares — an estimated $34.6K sold.

LMR Partners first reported a position in BNGO in Q4 2020 and held it in 2 quarters. The position peaked at $42K in Q4 2020. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • LMR Partners reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • LMR Partners sold 95 Bionano Genomics shares in Q3 2023, an estimated $34.6K.
  • LMR Partners first reported a position in Bionano Genomics in Q4 2020 and held it in 2 quarters.
  • LMR Partners's Bionano Genomics position peaked at $42K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on LMR Partners's 13F filing for Q3 2023, filed 14 Nov 2023.